BioPharmSignal logoBioPharmSignal

Biotech News

Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference

Immunocore Holdings plc (IMCR)Immunocore Holdings plcConference / presentation

IMCR (IMCR) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is imcr.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

TEVATeva Pharmaceutical Industries2026-06-01 20:30 EST

Teva to Present at the Goldman Sachs Global Healthcare Conference

ERASErasca2026-05-27 12:00 EST

Erasca to Present at the Jefferies Global Healthcare Conference

GERNGeron2026-06-01 12:00 EST

Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

COGTCogent Biosciences2026-05-27 12:00 EST

Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference

KYMRKymera2026-05-27 11:00 EST

Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

BMYBMYBristol-Myers Squibb Company2026-05-27 10:59 EST

Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

IDYAIDEAYA Biosciences2026-05-26 10:00 EST

IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference

BMYBMYBristol-Myers Squibb Company2026-05-06 10:59 EST

Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026

KURAKura Oncology2026-05-06 11:30 EST

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

ZNTLZentalis2026-07-17 20:15 EST

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

View all latest news

Immunocore Holdings plc

Immunocore is an immunotherapy company focused on T-cell receptor biology and oncology programs.

Recent company news

IMCRImmunocore Holdings plc2026-05-31 12:00 EST

Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma

IMCRImmunocore Holdings plc2026-05-06 11:00 EST

Immunocore reports first quarter financial results and provides a business update

IMCRImmunocore Holdings plc2026-04-19 22:00 EST

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

IMCRImmunocore Holdings plc2026-04-06 11:00 EST

Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference

IMCRImmunocore Holdings plc2026-03-17 20:30 EST

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting

Stock data

Close
33.77 USD
Market cap
1.5B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States